Literature DB >> 29883227

Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder.

Asmat Ullah Khan1,2, Muhammad Akram3, Muhammad Daniyal4,5, Rida Zainab3.   

Abstract

CONTEXT: Parkinson's disease (PD) is the second common progressive neurodegenerative disease, distressing older men and is prevalent Worldwide.
OBJECTIVES: This article is aimed to review the epidemiology, etiology, pathogenesis, clinical manifestation, diagnosis and management of PD.
METHODS: A google search was performed to recognise studies that review the characteristics of PD. Search terms included 'Parkinson's disease', 'epidemiology', 'etiology', 'pathogenesis', 'clinical manifestations', 'diagnosis' and 'management of Parkinson disease'.
RESULTS: PD is linked to factors such as environmental chemicals, aging, family history and pesticide exposure such as the use of synthetic heroin. PD is characterised clinically by tremors at rest, postural instability, expressionless countenance, lead pipe rigidity and less commonly cognitive impairment. After 60 years of age, PD is commonly prevalent in 1-% of the population, no racial differences are apparent, but the prevalence of PD is more common in men than women. There has also been a better understanding that the disorder may be linked with major non-motor trouble in addition to the additional generally recognised motor complications. There are various management options for the timely management of PD. As the ailment advances, further management strategies are existing; however, the management of non-motor manifestations and late stage motor complications remains mainly testing and will advantage from additional clinical studies.
CONCLUSIONS: In this article, we have discussed current progress in the understanding of the epidemiology, clinical manifestations, pathogenesis and management strategies of the disease.

Entities:  

Keywords:  Parkinson’s disease; dopaminergic pathways; motor system; neostriatum; substantia nigra pars compacta

Mesh:

Year:  2018        PMID: 29883227     DOI: 10.1080/00207454.2018.1486837

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  14 in total

1.  PBX1 attenuates 6-OHDA-induced oxidative stress and apoptosis and affects PINK1/PARKIN expression in dopaminergic neurons via FOXA1.

Authors:  Binglong Li; Di An; Shasha Zhu
Journal:  Cytotechnology       Date:  2022-01-24       Impact factor: 2.058

Review 2.  Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.

Authors:  Erin John Rieger de Almeida; Hélio Jungkenn Ibrahim; Maria Rosa Chitolina Schetinger; Cinthia Melazzo de Andrade; Andréia Machado Cardoso
Journal:  Neurochem Res       Date:  2022-08-13       Impact factor: 4.414

3.  Neural Networks to Recognize Patterns in Topographic Images of Cortical Electrical Activity of Patients with Neurological Diseases.

Authors:  Francisco Gerson A de Meneses; Ariel Soares Teles; Monara Nunes; Daniel da Silva Farias; Silmar Teixeira
Journal:  Brain Topogr       Date:  2022-05-21       Impact factor: 4.275

4.  Correlation between head tremble and the severity of Parkinson's disease.

Authors:  Jingsheng Yang; Quanhao Guo; Xianwei Zou; Meng Wang; Yanxia Wen; Xiaqing Chen; Xiechuan Weng; Fan Xu
Journal:  CNS Neurosci Ther       Date:  2021-11-10       Impact factor: 5.243

5.  Targeting TREM2 for Parkinson's Disease: Where to Go?

Authors:  Xiao-Xian Li; Feng Zhang
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

6.  Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis.

Authors:  Yue Lang; Hui Zhang; Haojia Yu; Yu Li; Xiao Liu; Minjie Li
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 7.  Benefits of Virtual Reality Balance Training for Patients With Parkinson Disease: Systematic Review, Meta-analysis, and Meta-Regression of a Randomized Controlled Trial.

Authors:  Jinlong Wu; Hui Zhang; Ziyan Chen; Ruijia Fu; Hao Yang; Hongfa Zeng; Zhanbing Ren
Journal:  JMIR Serious Games       Date:  2022-03-01       Impact factor: 3.364

Review 8.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11

9.  miR-101-3p Contributes to α-Synuclein Aggregation in Neural Cells through the miR-101-3p/SKP1/PLK2 Pathway.

Authors:  Min Zhang; Wei Liu; Qingan Zhang; Hongfeng Hu
Journal:  J Healthc Eng       Date:  2021-06-12       Impact factor: 2.682

10.  Review of medicine utilization for Parkinson's disease management: the Bulgarian perspective.

Authors:  Zornitsa Mitkova; Maria Kamusheva; Dobrinka Kalpachka; Desislava Ignatova; Konstantin Tachkov; Guenka Petrova
Journal:  J Public Health Res       Date:  2021-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.